BioWatch: VIVUS & Orexigen Looking More FDA-Favorable (VVUS, OREX, ARNA)

Miscellaneous | 24/7 Wall St. | April 4, 2011 6:38 am

VIVUS Inc. (NASDAQ: VVUS) was recently shown as one of our five biotechs with 50% upside and news this morning is showing why VIVUS may be one of the only possible diet drugs which can get approval even with the FDA concerns. Its shares are surging this morning on news that long-term QNEXA study data [...]

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]